I'm not concerned with JNJ's legal struggles, says Gradient's Montagne

Mariann Montagne, Gradient Investments portfolio manager, joins 'Power Lunch' to discuss why health care can outperform in a rising rate environment, if Bristol Meyers and Johnson & Johnson will continue acquiring companies and more.